European Investment Bank to Support Increased Vaccine Production in South Africa by Biovac

Preparatory work to outline production investment and determine regional vaccine needs backed by European Union; Expected EUR 175 million investment to scale up drug and vaccine development and manufacturing at Biovac Cape Town plant; New investment to enable manufacturing 500

APO Group